SEC 13F Intelligence

Gates Foundation / BNTX

Gates Foundation’s Biontech SE Position

Does Gates Foundation own Biontech SE (BNTX)? Yes — 148.7K shares worth $18M (+40.59% of its 13F portfolio) as of Q3 2024.

Position Value
$18M
Q3 2024
Shares
148.7K
% of Portfolio
+40.59%
Quarters Held
16
currently held

Position History BNTX

Reported value by quarter
Q4 ’20: $85MQ4 ’20Q1 ’21: $113MQ2 ’21: $233MQ2 ’21Q3 ’21: $41MQ4 ’21: $38MQ4 ’21Q1 ’22: $25MQ2 ’22: $22MQ2 ’22Q3 ’22: $20MQ4 ’22: $22MQ4 ’22Q1 ’23: $19MQ2 ’23: $16MQ2 ’23Q3 ’23: $16MQ4 ’23: $16MQ4 ’23Q1 ’24: $14MQ2 ’24: $12MQ2 ’24Q3 ’24: $18Mfilingsflow.com
QuarterSharesValue% of Portfolio
Q3 2024148.7K$18M+40.59%
Q2 2024148.7K$12M+19.99%
Q1 2024148.7K$14M+16.30%
Q4 2023148.7K$16M+17.46%
Q3 2023148.7K$16M+19.26%
Q2 2023148.7K$16M+12.77%
Q1 2023148.7K$19M+16.35%
Q4 2022148.7K$22M+17.21%
Q3 2022148.7K$20M+15.89%
Q2 2022148.7K$22M+17.06%
Q1 2022148.7K$25M+13.66%
Q4 2021148.7K$38M+11.62%
Q3 2021148.7K$41M+11.89%
Q2 20211.04M$233M+33.68%
Q1 20211.04M$113M+17.29%
Q4 20201.04M$85M+19.42%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Gates Foundation’s full portfolio or all institutional holders of BNTX.